# EMFLAZA

NDC: 52856-503
Generic name: deflazacort
Labeler / Manufacturer: PTC Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20180910

FDA application: NDA208684

## Active ingredients

- DEFLAZACORT: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52856-503"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52856-503
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31b347d2-f156-4055-9d8f-7cf0df420296